Functional and developmental studies of the peripheral arterial chemoreceptors in rat: effects of nicotine and possible relation to sudden infant death syndrome.
The drive on respiration mediated by the peripheral arterial chemoreceptors was assessed by the hyperoxic test in 3-day-old rat pups. They accounted for 22.5 +/- 8.8% during control conditions, but only for 6.9 +/- 10.0% after nicotine exposure, an effect counteracted by blockade of peripheral dopamine type 2 receptors (DA2Rs). Furthermore, nicotine reduced dopamine (DA) content and increased the expression of tyrosine hydroxylase (TH) in the carotid bodies, further suggesting that DA mediates the acute effect of nicotine on arterial chemoreceptor function. During postnatal development TH and DA2R mRNA levels in the carotid bodies decreased. Thus, nicotine from smoking may also interfere with the postnatal resetting of the oxygen sensitivity of the peripheral arterial chemoreceptors by increasing carotid body TH mRNA, as well as DA release in this period. Collectively these effects of nicotine on the peripheral arterial chemoreceptors may increase the vulnerability to hypoxic episodes and attenuate the protective chemoreflex response. These mechanisms may underlie the well-known relation between maternal smoking and sudden infant death syndrome.
Holgert
H
H
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Hökfelt
T
T
Hertzberg
T
T
Lagercrantz
H
H
D000818:Animals; D001158:Arteries / Q000294:innervation*; D002344:Carotid Body / Q000503:physiopathology; D002628:Chemoreceptor Cells / Q000187:drug effects* / Q000503:physiopathology; D004298:Dopamine / Q000096:biosynthesis; D005260:Female; D006801:Humans; D017403:In Situ Hybridization; D007223:Infant; D008297:Male; D008431:Maternal-Fetal Exchange; D009538:Nicotine / Q000009:adverse effects*; D011247:Pregnancy; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000235:genetics; D012907:Smoking / Q000009:adverse effects; D013398:Sudden Infant Death / Q000209:etiology*; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics
D012333:RNA, Messenger; D017448:Receptors, Dopamine D2; D009538:Nicotine; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine